Category

The following is a letter from the Chairman of BioElectronics Corporation (OTC Pink: BIEL) to shareholders: October 22, 2015 Dear Biel Shareholders: This has been a busy last few months that has resulted in some very positive news for BIEL shareholders and I want to take a few minutes to put these events in perspective. … Continue Reading

FREDERICK, MD. October 20, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received initial orders for its ActiPatch® Musculoskeletal Pain Relief products for 1,077 Lloyd’s pharmacies, the second largest chain in the UK, and Gordons Chemist. ActiPatch will be on promotion in … Continue Reading

FREDERICK, MD. October 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management endorsed the U.S. Food and Drug Administration’s final rule 890.5290 on nonthermal pulsed shortwave devices published today in the Federal Register. “I am pleased the agency has completed this step in streamlining the regulatory requirements … Continue Reading

Osteoarthritis is the Most Common Cause of Disability FREDERICK, MD. September 21, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced that they are sponsoring the Arthritis Care Time for Tea campaign October 12-18, 2015. Time for Tea is organized by Arthritis Care, a registered UK charity … Continue Reading

FREDERICK, MD, USA, August 27, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that three abstracts featuring the use of ActiPatch®, its novel musculoskeletal pain therapy, will be presented at the 9th Congress of the European Pain Federation EFIC®, Vienna, Austria, 2-5th September 2015. The Company will … Continue Reading

Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales

FREDERICK, MD, USA, August 18, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy.

The Most Innovative Treatment for Chronic Pain FREDERICK, MD. August 10, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced the filing of a 510(k) Premarket Notification for ActiPatch® Therapy with the U.S. Food and Drug Administration. The market clearance request is for the adjunctive treatment of … Continue Reading

FREDERICK, MD, USA, August 4, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of drug-free over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced today that its registry study of 44,000 users of its ActiPatch 7-day trial device has been published in the prominent peer reviewed medical journal Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35. More than 5,000 chronic … Continue Reading

Topics will Include UK Progress and New Clinical Publications FREDERICK, MD.  August 3, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President will be interviewed by Stu Taylor on his program “On Business“ at 9am EST on Wednesday, August 5th. Listen to … Continue Reading

Appoints Market Leader, Medikon, LTD as distributor in Turkey FREDERICK, MD, USA, March 23, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced today that it has signed Medikon, one of the country’s leading medical suppliers as the distributor for RecoveryRx® Therapy for post-operative and chronic wound care, ActiPatch® Musculoskeletal … Continue Reading